FindTrial
Sign In

Assessment of role of MRI in neonatal encephalopathies

Role of Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging in the evaluation and prognostication of neonatal encephalopathies. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055568
Enrollment
41
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE]

Interventions

Intervention1: NIL: NIL

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with diagnosed encephalopathy, or showing any of 3 symptoms- altered mental status, recurrent seizures, abnormal neurological function

Exclusion criteria

Exclusion criteria: Neonates with severe congenital cardiac/ cerebral anomalies Known chromosomal anomalies

Design outcomes

Primary

MeasureTime frame
Lac Cr spectroscopy ratio in specific areas of brain to determine values for categorization by severity of disease Fractional Anisotropy values through diffusion tensor imaging to determine extent of involvement of tracts & correlation with clinical outcome Timepoint: one year from beginning data collection (baseline) - 31st july 2024—

Secondary

MeasureTime frame
Broad clinical outcomes of child Death or Cerebral Palsy or Delayed development or NormalTimepoint: 2 years from baseline- 31st july 2025—

Countries

India

Contacts

Public ContactDr Priya P S

Kasturba Medical College, Manipal

priya.psankaran@gmail.com9895563264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026